We sure could use something. Six months ago we were all on the CC when we were in the .60's, and a lot of talk by management over the past year. Where is Generex with all these plans anyway? For example, I was looking at the Feb 2019 about a Regentys trial that was supposed to start later 2019. Haven't heard much about that since the PR. hope the upcoming CC has some concrete developments to share. As Todd would say, "so much in the hopper". Arizona MSO, NGIO listing, GNBT upliisting, Olaregen ( Excellagen, other products), Regentys, NuGenerex Diagnostics ( what do they actually sell?), COVID19 ( China, and BARDA proposal). Also, what about the issue with Creek Mountain and that securities specialist looking into them puking shares?